Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 12, 2015, Pages 1347-1355

  Antoine, Jean Christophe ^a,b,c,d   Boutahar, Nadia ^a,b,d   Lassablière, François ^b   Reynaud, Evelyne ^a   Ferraud, Karine ^a   Rogemond, Véronique ^c,d   Paul, Stéphane ^a,b,c   Honnorat, Jérôme ^c,d,e   Camdessanché, Jean Philippe ^a,b,c,d  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

^d CNRS   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3 ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 3; NERVE PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CELL ASSAY; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LUPUS VULGARIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; PAIN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MICROARRAY; PROTEIN TARGETING; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR NEUROPATHY; SENSORY NERVE CELL; SENSORY NEUROPATHY; SPINAL GANGLION; TRIGEMINAL NERVE; ANTIBODY SPECIFICITY; HEK293 CELL LINE; IMMUNOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES;

ADULT; AGED; ANTIBODIES; ANTIBODY SPECIFICITY; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RETROSPECTIVE STUDIES; SENSORY RECEPTOR CELLS;

EID: 84956590325     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309730     Document Type: Article

References (33)

1. Kuntzer T, Antoine JC, Steck AJ. Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve 2004;30:255-68.
2. Sghirlanzoni A, Pareyson D, Lauria G. Sensory neuron diseases. Lancet Neurol 2005;4:349-61.
3. Graus F, Ribalta T, Campo E, et al. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990;40:219-22.
4. Dalmau J, Furneaux HM, Rosenblum MK, et al. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991;41:1757-64.
5. Wanschitz J, Hainfellner JA, Kristoferitsch W, et al. Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study. Neurology 1997;49:1156-9.
6. Scaravilli F, Sinclair E, Arango JC, et al. The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta Neuropathol 1992;84:163-70.
7. Esiri MM, Morris CS, Millard PR. Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 1993;114:178-87.
8. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 2005;128(Pt 11):2518-34.
9. Griffin JW, Cornblath DR, Alexander E, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol 1990;27:304-15.
10. Okajima T, Yamamura S, Hamada K, et al. Chronic sensory and autonomic neuropathy. Neurology 1983;33:1061-4.
11. Sobue G, Yanagi T, Hashizume Y. Chronic progressive sensory ataxic neuropathy with polyclonal gammopathy and disseminated focal perivascular cellular infiltrations. Neurology 1988;38:463-7.
12. Hainfellner JA, Kristoferitsch W, Lassmann H, et al. T-cell-mediated ganglionitis associated with acute sensory neuronopathy. Ann Neurol 1996;39:543-7.
13. Kurokawa K, Noda K, Mimori Y, et al. A case of pandysautonomia with associated sensory ganglionopathy. J Neurol Neurosurg Psychiatry 1998;65:278-9.
14. Colli BO, Carlotti CG Jr, Assirati JA Jr, et al. Dorsal root ganglionectomy for the diagnosis of sensory neuropathies. Surgical technique and results. Surg Neurol 2008;69:266-73; dicussion 73.
15. Camdessanche JP, Jousserand G, Ferraud K, et al. The pattern and diagnostic criteria of sensory neuronopathy: a case-control study. Brain 2009;132(Pt 7):1723-33.
16. Camdessanche JP, Jousserand G, Franques J, et al; French CIDP study group. A clinical pattern-based etiological diagnostic strategy for sensory neuronopathies: a French collaborative study. J Peripher Nerv Syst 2012;17:331-40.
17. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.
18. Camdessanche JP, Antoine JC, Honnorat J, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 2002;125(Pt 1):166-75.
19. Murata Y, Maeda K, Kawai H, et al. Antiganglion neuron antibodies correlate with neuropathy in Sjogren's syndrome. Neuroreport 2005;16:677-81.
20. Eystathioy T, Chan EK, Takeuchi K, et al. Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182. J Mol Med 2003;81:811-18.
21. Dalakas MC. Chronic idiopathic ataxic neuropathy. Ann Neurol 1986;19:545-54.
22. Nemni R, Camerlingo M, Fazio R, et al. Serum antibodies to Purkinje cells and dorsal root ganglia neurons in sensory neuronopathy without malignancy. Ann Neurol 1993;34:848-54.
23. Mutoh T, Tachi M, Yano S, et al. Impairment of Trk-neurotrophin receptor by the serum of a patient with subacute sensory neuropathy. Arch Neurol 2005;62:1612-15.
24. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010;10:116-29.
25. Mason I. Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat Rev Neurosci 2007;8:583-96.
26. Guillemot F, Zimmer C. From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 2011;71:574-88.
27. Hughes SE. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 1997;45:1005-19.
28. Grothe C, Meisinger C, Claus P. In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia. J Comp Neurol 2001;434:342-57.
29. Jungnickel J, Klutzny A, Guhr S, et al. Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants. Neuroscience 2005;134:1343-50.
30. Grothe C, Haastert K, Jungnickel J. Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration - lessons from in vivo studies in mice and rats. Brain Res Rev 2006;51:293-9.
31. Furusho M, Dupree JL, Bryant M, et al. Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 2009;29:1608-14.
32. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83: 280-91.
33. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013;84:748-55.